#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4149814	F	Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assay	Homo sapiens	18	ALA4145595	cell-based format	Scientific Literature
2.	ALA4149815	F	Agonist activity at mouse GPR119 assessed as increase in cAMP level	Mus musculus	18	ALA4145595	assay format	Scientific Literature
3.	ALA4149816	F	Glucose lowering effect in C57Bl/6NCrl mouse assessed as reduction in glucose level at 3 mg/kg, po administered via gavage pretreated for 30 mins followed by glucose-challenge measured after 20 mins by OGTT relative to control	Mus musculus	11	ALA4145595	organism-based format	Scientific Literature
4.	ALA4149820	A	Plasma clearance in rat at 1 mg/kg, iv or 3 mg/kg, po	Rattus norvegicus	1	ALA4145595	organism-based format	Scientific Literature
5.	ALA4149821	A	Volume of distribution at steady state in rat at 1 mg/kg, iv or 3 mg/kg, po	Rattus norvegicus	1	ALA4145595	organism-based format	Scientific Literature
6.	ALA4149822	A	Half life in rat at 1 mg/kg, iv or 3 mg/kg, po	Rattus norvegicus	1	ALA4145595	organism-based format	Scientific Literature
7.	ALA4149823	A	AUC in rat at 3 mg/kg, po	Rattus norvegicus	1	ALA4145595	organism-based format	Scientific Literature
8.	ALA4149824	A	Oral bioavailability in rat at 3 mg/kg	Rattus norvegicus	1	ALA4145595	organism-based format	Scientific Literature
9.	ALA4149825	A	Plasma clearance in monkey at 1 mg/kg, iv or 3 mg/kg, po	Macaca mulatta	1	ALA4145595	organism-based format	Scientific Literature
10.	ALA4149826	A	Volume of distribution at steady state in monkey at 1 mg/kg, iv or 3 mg/kg, po	Macaca mulatta	1	ALA4145595	organism-based format	Scientific Literature
11.	ALA4149827	A	Half life in monkey at 1 mg/kg, iv or 3 mg/kg, po	Macaca mulatta	1	ALA4145595	organism-based format	Scientific Literature
12.	ALA4149828	A	AUC in monkey at 3 mg/kg, po	Macaca mulatta	1	ALA4145595	organism-based format	Scientific Literature
13.	ALA4149829	A	Oral bioavailability in monkey at 3 mg/kg	Macaca mulatta	1	ALA4145595	organism-based format	Scientific Literature
14.	ALA4149830	A	Plasma clearance in dog at 1 mg/kg, iv or 3 mg/kg, po	Canis lupus familiaris	1	ALA4145595	organism-based format	Scientific Literature
15.	ALA4149831	A	Volume of distribution at steady state in dog at 1 mg/kg, iv or 3 mg/kg, po	Canis lupus familiaris	1	ALA4145595	organism-based format	Scientific Literature
16.	ALA4149832	A	Half life in dog at 1 mg/kg, iv or 3 mg/kg, po	Canis lupus familiaris	1	ALA4145595	organism-based format	Scientific Literature
17.	ALA4149833	A	AUC in dog at 3 mg/kg, po	Canis lupus familiaris	1	ALA4145595	organism-based format	Scientific Literature
18.	ALA4149834	F	Antidiabetic activity in C57Bl/6NCrl mouse assessed as reduction in glucose excursion administered via oral gavage pretreated for 30 mins followed by glucose-challenge measured 60 mins post dose by OGTT	Mus musculus	1	ALA4145595	organism-based format	Scientific Literature
19.	ALA4149835	F	Antidiabetic activity in C57Bl/6NCrl mouse assessed as reduction in glucose excursion at 0.03 mg/kg, po administered via gavage pretreated for 30 mins followed by glucose-challenge measured 60 mins post dose by OGTT relative to control	Mus musculus	1	ALA4145595	organism-based format	Scientific Literature
20.	ALA4149836	F	Antidiabetic activity in C57Bl/6NCrl mouse assessed as reduction in glucose excursion at 0.1 mg/kg, po administered via gavage pretreated for 30 mins followed by glucose-challenge measured 60 mins post dose by OGTT relative to control	Mus musculus	1	ALA4145595	organism-based format	Scientific Literature